Diabetes Clinical Trials in San Antonio

Showing 241-260 of 283 trials

Screening for Early Evidence of Diabetes

NCT00614783

This is a pivotal study to determine the accuracy of a new device (SCOUT) in screening persons for pre-diabetes or diabetes. SCOUT will be compared to the standard screening test (Fasting Plasma Glucose), using the Oral Glucose Tolerance Test as the reference standard. SCOUT uses a rapid, noninvasive, light-based technology to measure the concentration of chemicals in the skin called advanced glycation endproducts (AGEs). Several studies have demonstrated that AGEs accumulate in skin faster in individuals with poor control of blood sugar. Persons will be eligible for the study if they are 'at risk' for diabetes based on their age and other risk factors as defined by the American Diabetes Association.

Diabetes Mellitus, Type 2

VeraLight, Inc.3,478 participantsStarted May 2007

Huntsville, Alabama, United States • San Diego, California, United States • San Diego, California, United States +12 more locations

COMPLETEDPHASE2< 1 mile

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

NCT00476931

The purpose of the study is to study the clinical effects of the investigational drug, SB-509 versus placebo in patients with diabetic neuropathy.

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy

Sangamo Therapeutics91 participantsStarted May 2007

La Jolla, California, United States • Lakewood, California, United States • Lomita, California, United States +17 more locations

Screening for Early Evidence of Diabetes

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Diabetes Trials in Other Cities

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

Follow-Up Study for Exubera

Mechanisms of Glucose Lowering Effect of Colesevelam HCl

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

WelChol® and Insulin in Treating Patients With Type 2 Diabetes

The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study

Study To Assess the Pharmacokinetics of AZD1656 During Coadministration With Simvastatin

Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment

A Study for Patients With Type 2 Diabetes Mellitus

GALLANT 6 Tesaglitazar vs. Pioglitazone

DPBRN Blood Sugar Testing in Dental Patients

Testing the Developmental Origins Hypothesis

Blood Glucose Testing and You

Other Conditions in San Antonio